Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Policy implications for post-Brexit biotech

Subjects

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: UK 'Brexit' pathways.

References

  1. Cressey, D. & Abbott, A. Nature http://dx.doi.org/10.1038/nature.2016.20153 (2016).

  2. Anonymous. Nature 544, 6 (2017).

  3. European Commission. Swiss participation in Horizon 2020. http://ec.europa.eu/research/participants/data/ref/h2020/other/hi/h2020-hi-swiss-part_en.pdf (EU, 2017).

  4. Matthes, J. & Busch, B. Vox http://voxeu.org/article/meta-analysis-economic-impact-brexit (2016).

  5. Pain, N. & Young, G. Econ. Model. 21, 387–408 (2004).

    Article  Google Scholar 

  6. Abraham, J. Lancet 360, 1498–1502 (2002).

    Article  Google Scholar 

  7. Lang, A. House of Commons Library http://researchbriefings.parliament.uk/ResearchBriefing/Summary/SN06522#fullreport (2013).

    Google Scholar 

  8. Mossialos, E., Simpkin, V., Keown, O. & Darzi, A. LSE http://www.lse.ac.uk/LSEHealthAndSocialCare/impacts/news/NHS-and-EU-Referendum-briefing.pdf (2016).

  9. Gibney, E. Nature 540, 16–17 (2016).

    CAS  Article  Google Scholar 

  10. Cressey, D. Nature http://dx.doi.org/10.1038/nature.2016.20434 (2016).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tim K Mackey.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Annaloro, J., Mackey, T. Policy implications for post-Brexit biotech. Nat Biotechnol 35, 710–711 (2017). https://doi.org/10.1038/nbt.3930

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3930

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing